Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | CHKA | P35790 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | VNN1 | O95497 | 1/20 | 0.39 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL4461520 | 0.97 | MAOB (0.54) | MAOBMAOACHKACYP2A6CYP19A1 | |
| SCHEMBL9871410 | 0.97 | MAOB (0.56) | MAOBMAOACHKACYP2A6CYP19A1 | |
| Fluoride Ion SCHEMBL4075178 | 0.78 | CHKA (0.49) | MAOBMAOACHKAMEN1KMT2A | |
| SCHEMBL7837346 | 0.78 | CHKA (0.49) | MAOBCHKAIDO1 | |
| Fluoride Ion SCHEMBL125569 | 0.76 | CHKA (0.68) | CHKA | |
| SCHEMBL9249583 | 0.76 | TSHR (0.45) | MAOBMAOACHKAPOLBMAPT | |
| Fluoride Ion SCHEMBL4075175 | 0.75 | CHKA (0.49) | MAOBMAOACHKAMEN1KMT2A | |
| SCHEMBL20053881 | 0.74 | MAOB (0.65) | MAOBMAOACYP2A6CYP19A1POLB | |
| SCHEMBL4356760 | 0.74 | CHKA (0.52) | MAOBMAOACHKACYP2A6MEN1 | |
| SCHEMBL7316077 | 0.74 | MAOB (0.65) | MAOBMAOACYP2A6CYP19A1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1791824-B1 | RADICALLY POLYMERIZABLE SULFUR-CONTAINING COMPOUND AND RADICALLY POLYMERIZABLE SULFUR-CONTAINING POLYMER | SHOWA DENKO KK (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090192279-A1 | Radically Polymerizable Sulfur-Containing Compound and Radically Polymerizable Sulfur-Containing Polymer | SHOWA DENKO K.K. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-7518001-B2 | Radically polymerizable sulfur-containing compound and radically polymerizable sulfur-containing polymer | SHOWA DENKO K.K. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20070208149-A1 | Radically Polymerizable Sulfur-Containing Compound And Radically Polymerizable Sulfur-Containing Polymer | SHOWA DENKO K.K. (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1791824-A1 | RADICALLY POLYMERIZABLE SULFUR-CONTAINING COMPOUND AND RADICALLY POLYMERIZABLE SULFUR-CONTAINING POLYMER | Showa Denko K.K. (JP) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006033438-A1 | RADICALLY POLYMERIZABLE SULFUR-CONTAINING COMPOUND AND RADICALLY POLYMERIZABLE SULFUR-CONTAINING POLYMER | SHOWA DENKO K.K. (JP) | 2006-03-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208149-A1 | Radically Polymerizable Sulfur-Containing Compound And Radically Polymerizable Sulfur-Containing Polymer | CBS, TST, MSRB3 | MAOB 4541/4885MAOA 4205/4885CHKA 2923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.